Concert revises Phase lla trial design to add new CTP-543 dose
Concert Pharmaceuticals has amended the protocol of a Phase lla trial evaluating CTP-543 for the...
Concert Pharmaceuticals has amended the protocol of a Phase lla trial evaluating CTP-543 for the...